Évaluation de la pratique de l’amniocentèse sur le réseau sud-ouest francilien pendant l’année 2003
暂无分享,去创建一个
[1] R. Frydman,et al. Fear of Pregnancy Loss and Fetal Karyotyping: A Place for Third-Trimester Amniocentesis? , 2007, Fetal Diagnosis and Therapy.
[2] F. Malone,et al. Pregnancy Loss Rates After Midtrimester Amniocentesis , 2006, Obstetrics and gynecology.
[3] D. Sahota,et al. Risk factors for procedure‐related fetal losses after mid‐trimester genetic amniocentesis , 2006, Prenatal diagnosis.
[4] A. Caughey,et al. Chorionic Villus Sampling Compared With Amniocentesis and the Difference in the Rate of Pregnancy Loss , 2006, Obstetrics and gynecology.
[5] J. Pezzullo,et al. Risk of third-trimester amniocentesis: a case-control study. , 2006, American journal of perinatology.
[6] M. Muhcu,et al. Pregnancy outcome following second-trimester amniocentesis: a case-control study. , 2006, American journal of perinatology.
[7] B. Brambati,et al. Chorionic villus sampling and amniocentesis , 2005, Current opinion in obstetrics & gynecology.
[8] O. Axelsson,et al. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping , 2005, BJOG: an International Journal of Obstetrics and Gynaecology.
[9] J. Seeds. Diagnostic mid trimester amniocentesis: how safe? , 2004, American journal of obstetrics and gynecology.
[10] O. Gómez-Marín,et al. Genetic Amniocentesis Complications: Is the Incidence Overrated? , 2004, Gynecologic and Obstetric Investigation.
[11] J. Philip,et al. Late First-Trimester Invasive Prenatal Diagnosis: Results of an International Randomized Trial , 2004, Obstetrics and gynecology.
[12] A. Thelin,et al. Early Amniocentesis and Congenital Foot Deformities , 2002, Fetal Diagnosis and Therapy.
[13] Y. Ville,et al. Down's syndrome screening with nuchal translucency at 12(+0)-14(+0) weeks and maternal serum markers at 14(+1)-17(+0) weeks: a prospective study. , 2002, Human reproduction.
[14] W. Barth,et al. Complications of Third‐Trimester Amniocentesis Using Continuous Ultrasound Guidance , 2002, Obstetrics and gynecology.
[15] R. Frydman,et al. Is Routine Amniocentesis for Advanced Maternal Age Still Indicated? , 2001, Fetal Diagnosis and Therapy.
[16] E. Ogris,et al. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low‐risk population , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[17] R. Frydman,et al. Screening for Down syndrome using first‐trimester ultrasound and second‐trimester maternal serum markers in a low‐risk population: a prospective longitudinal study , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[18] A. Zejli,et al. [Amniotic fluid leakage and premature rupture of membranes after amniocentesis. A review of the literature]. , 2000, Journal de gynecologie, obstetrique et biologie de la reproduction.
[19] N. Papantoniou,et al. Genetic amniocentesis in women 20–34 years old: associated risks , 2000, Prenatal diagnosis.
[20] N. Okun,et al. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian early (EA) versus mid‐trimester (MA) amniocentesis trial , 1999, Prenatal Diagnosis.
[21] N. Nevin,et al. Early amniocentesis: effect of removing a reduced volume of amniotic fluid on pregnancy outcome , 1998, Prenatal diagnosis.
[22] C. Lundsteen,et al. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling , 1997, The Lancet.
[23] M. Hammar,et al. Transplacental needle passage and other risk‐factors associated with second trimester amniocentesis , 1997, Acta obstetricia et gynecologica Scandinavica.
[24] B. Eiben,et al. On the complication risk of early amniocentesis versus standard amniocentesis. , 1997, Fetal diagnosis and therapy.
[25] R. O. Davis,et al. Pregnancy Outcome Following Genetic Amniocentesis at 11–14 Versus 16–19 Weeks' Gestation , 1996, Obstetrics and gynecology.
[26] A. Bombard,et al. Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis. , 1995, American journal of obstetrics and gynecology.
[27] K. Nicolaides,et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation , 1994, The Lancet.
[28] C. Trujillo,et al. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis. , 1990, American journal of medical genetics.
[29] Ann Tabor,et al. RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN , 1986, The Lancet.